What is the price target for OCGN stock?
11 analysts have analysed OCGN and the average price target is 9.18 USD. This implies a price increase of 293.99% is expected in the next year compared to the current price of 2.33.
NASDAQ:OCGN • US67577C1053
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OCUGEN INC (OCGN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-11 | Oppenheimer | Initiate | Outperform |
| 2026-03-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-01-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-23 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-15 | Maxim Group | Initiate | Buy |
| 2024-05-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.036M | 4.055M -32.82% | 4.413M 8.83% | 3.142M -28.80% | 133.19M 4,139.02% | 480.8M 260.99% | 1.049B 118.18% | 1.709B 62.92% | 2.643B 54.65% | 3.385B 28.07% | 3.853B 13.83% | |
| EBITDA YoY % growth | -64.827M 23.18% | -52.789M 18.57% | -60.527M -14.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -65.531M 22.79% | -54.757M 16.44% | -62.916M -14.90% | -78.703M -25.09% | -11.754M 85.07% | 166.79M 1,519.01% | 522.03M 212.99% | 887.81M 70.07% | 1.573B 77.18% | 1.935B 23.01% | 2.241B 15.81% | |
| Operating Margin | -1,085.67% | -1,350.36% | -1,425.70% | -2,504.88% | -8.82% | 34.69% | 49.76% | 51.95% | 59.52% | 57.16% | 58.16% | |
| EPS YoY % growth | -0.24 36.84% | -0.19 20.83% | -0.23 -21.05% | -0.24 -4.66% | -0.04 85.17% | 0.08 328.57% | 0.86 950.00% | 1.36 58.33% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 -14.24% | -0.06 -17.30% | -0.06 16.21% | -0.06 -2.00% |
| Revenue Q2Q % growth | 510K -65.56% | 561K -59.14% | 612K -65.07% | 951.997K 593.26% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.78M -15.72% | -16.072M -16.50% | -16.824M 4.54% | -17.201M 8.58% |
All data in USD
11 analysts have analysed OCGN and the average price target is 9.18 USD. This implies a price increase of 293.99% is expected in the next year compared to the current price of 2.33.
OCUGEN INC (OCGN) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of OCUGEN INC (OCGN) is -0.06 USD and the consensus revenue estimate is 510.00K USD.
The expected long term growth rate for OCUGEN INC (OCGN) is 343.55%.